![]() |
市場調查報告書
商品編碼
1933295
全球血液透析機市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測(2026-2034)Hemodialysis Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球血液透析機市場規模達到154.4億美元,預計從2026年的164.8億美元成長至2034年的312.3億美元,在預測期(2026-2034年)內年複合成長率(CAGR)為8.32%。北美地區憑藉其先進的醫療基礎設施和慢性腎臟病(CKD)的高發病率,在2025年佔據全球市場38.11%的佔有率。
血液透析是腎衰竭患者維持生命的血液淨化過程。它使用透析器(也稱為人工腎臟)來清除血液中的毒素和多餘液體。治療可在中心進行,也可居家進行,由於居家治療的靈活性和生活品質的提高,越來越多的患者選擇居家治療。
市場概覽
全球末期腎病(ESRD)病例的增加是推動血液透析機需求的主要因素。糖尿病、高血壓、肥胖、遺傳性疾病和過量飲酒等因素都會顯著增加腎衰竭的風險。根據美國疾病管制與預防中心(CDC)的資料,糖尿病仍然是已開發經濟體中 ESRD 的主要原因。
由於住院病患急性腎損傷病例的增加,COVID-19 疫情暫時加速了對透析機的需求。儘管供應鏈中斷和勞動力短缺限制了市場成長,但市場在2021年至2023年期間趨於穩定,並在2024年恢復到疫情前的成長水準。這有望支撐市場在2034年之前的長期擴張。
市場驅動因素
慢性腎臟病(CKD)盛行率上升
全球CKD和末期腎病(ESRD)盛行率的上升是市場成長的主要驅動因素。根據Fresenius Medical Care的資料,2022年全球約有480萬人患有腎衰竭,預計到2033年這一數字將超過650萬人。光是2022年,全球就有約390萬名患者接受透析治療,將顯著增加對透析機、透析器和透析液的需求。
透析設備的技術進步
製造商正加大研發投入,以推出更安全、更緊湊、技術更先進的血液透析系統。諸如改進的液體管理技術、穿戴式腎臟和感染預防配件等創新技術,加速其在醫院和家庭醫療保健機構的普及應用。
市場限制因子
儘管需求強勁,但高昂的治療費用仍然是一大挑戰。每年的透析費用從 1萬美元到 9萬美元不等,其中中心血液透析的平均費用為每位患者每年 7.2萬美元到 8.8萬美元。此外,人們對某些透析設備可能造成的感染風險和有害化合物暴露的擔憂,導致監管審查力度加大,這可能會限制其在對成本敏感地區的普及。
市場趨勢
居家血液透析普及率不斷提高
影響市場的關鍵趨勢之一是向家庭透析解決方案的轉變。由於減少了診所就診次數、提高了靈活性並改善了治療效果,患者越來越傾向於選擇居家透析。 Max@Home 和 NephroPlus(2021)等合作項目以及主要製造商推出的先進家庭透析系統加速這一趨勢,尤其是在已開發國家。
細分市場分析
依產品劃分
市場依產品分為血液透析機和血液透析耗材。
預計到2026年,耗材細分市場將佔據主導地位,市場佔有率達到 84.51%,這主要得益於對透析器、透析液和血管通路產品的持續需求。由於政府大力推廣居家透析,預計透析設備市場將穩定成長。
依最終使用者劃分
由於透析手術量大且擁有專業的醫療基礎設施,預計到2026年,透析中心和醫院將佔據最大市場佔有率(83.57%)。由於便攜式和用戶友善系統的日益普及,預計居家醫療保健市場將以顯著的年複合成長率成長。
區域洞察
到2025年,北美市場規模達到 58.9億美元,這主要得益於終末期腎病(ESRD)患病率的上升以及家用透析設備的快速普及。
歐洲則位居第二,這得益於相對寬鬆的監管審批流程和健全的醫療保健體系,其中德國和英國的成長尤為顯著。
預計到2034年,亞太地區將實現最高的年複合成長率,這主要得益於中國、日本和印度透析基礎設施的擴張。
由於透析中心就診患者數量的增加,預計拉丁美洲以及中東和非洲地區將保持穩定成長。
The global hemodialysis equipment market was valued at USD 15.44 billion in 2025 and is projected to grow from USD 16.48 billion in 2026 to USD 31.23 billion by 2034, registering a CAGR of 8.32% during the forecast period (2026-2034). North America dominated the global market in 2025 with a 38.11% share, supported by advanced healthcare infrastructure and a high prevalence of chronic kidney disease (CKD).
Hemodialysis is a life-sustaining blood purification process used for patients with kidney failure, in which a dialyzer, often referred to as an artificial kidney, removes toxins and excess fluids from the blood. Treatment is delivered either through in-center hemodialysis or home-based hemodialysis, with growing patient preference for home-based modalities due to flexibility and improved quality of life.
MARKET OVERVIEW
The increasing global burden of end-stage renal disease (ESRD) is a major factor driving the demand for hemodialysis equipment. Conditions such as diabetes, hypertension, obesity, genetic disorders, and excessive alcohol consumption significantly contribute to kidney failure. According to CDC data, diabetes remains the leading cause of ESRD in developed economies.
The COVID-19 pandemic temporarily accelerated demand for dialysis equipment due to acute kidney failure cases among hospitalized patients. Although supply-chain disruptions and workforce shortages constrained growth, the market stabilized during 2021-2023 and is expected to return to pre-pandemic growth levels by 2024, supporting long-term expansion through 2034.
MARKET DRIVERS
Rising Prevalence of Chronic Kidney Disease
The growing prevalence of CKD and ESRD worldwide is the primary driver of market growth. According to Fresenius Medical Care, around 4.8 million people suffered from kidney failure in 2022, a figure projected to exceed 6.5 million by 2033. In 2022 alone, approximately 3.9 million patients globally underwent dialysis treatment, significantly increasing demand for machines, dialyzers, and dialysate.
Technological Advancements in Dialysis Equipment
Manufacturers are increasingly investing in R&D to introduce safer, compact, and technologically advanced hemodialysis systems. Innovations such as improved fluid management, wearable kidneys, and infection-prevention accessories are accelerating adoption across hospitals and home-care settings.
MARKET RESTRAINTS
Despite strong demand, high treatment costs remain a major challenge. Annual dialysis costs range from USD 10,000 to USD 90,000, with in-center hemodialysis averaging USD 72,000-88,000 per patient per year. Additionally, concerns related to infection risks and exposure to toxic compounds from certain dialysis machines have prompted regulatory scrutiny, potentially limiting adoption in cost-sensitive regions.
MARKET TRENDS
Growing Adoption of Home-Based Hemodialysis
A key trend shaping the market is the shift toward home-based dialysis solutions. Patients increasingly prefer home dialysis due to reduced hospital visits, flexibility, and improved outcomes. Partnerships such as Max@Home and NephroPlus (2021) and the launch of advanced home systems by leading manufacturers are accelerating this trend, particularly in developed economies.
SEGMENTATION ANALYSIS
By Product
The market is segmented into hemodialysis machines and hemodialysis consumables.
The consumables segment dominated the market in 2026 with an 84.51% share, driven by the recurring demand for dialyzers, dialysate, and vascular access products. The machines segment is expected to witness steady growth due to government initiatives promoting home dialysis adoption.
By End User
Dialysis centers & hospitals held the largest share in 2026 (83.57%), owing to the high volume of dialysis procedures and the presence of specialized infrastructure. The home healthcare segment is projected to grow at a significant CAGR due to increasing availability of portable and user-friendly systems.
REGIONAL INSIGHTS
North America generated USD 5.89 billion in 2025, driven by rising ESRD prevalence and rapid adoption of home-based machines.
Europe ranked second, supported by favorable regulatory approvals and strong healthcare systems, with Germany and the UK showing notable growth.
Asia Pacific is expected to register the highest CAGR through 2034, fueled by expanding dialysis infrastructure in China, Japan, and India.
Latin America and the Middle East & Africa are witnessing steady growth due to increasing patient visits to dialysis centers.
COMPETITIVE LANDSCAPE
The market is dominated by Fresenius Medical Care and Baxter, supported by extensive product portfolios and strong distribution networks. Other key players include B. Braun SE, NIPRO Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical, Medtronic, and JMS Co., Ltd. Strategic partnerships, FDA approvals, and new product launches continue to strengthen competitive positioning.
CONCLUSION
The global hemodialysis equipment market is poised for robust growth, driven by the rising prevalence of chronic kidney disease, technological advancements, and increasing adoption of home-based dialysis solutions. With the market expanding from USD 15.44 billion in 2025 to USD 31.23 billion by 2034, sustained investments in innovation, supportive government initiatives, and expanding dialysis infrastructure are expected to enhance patient access and treatment outcomes. Despite challenges related to high costs and safety concerns, the long-term outlook remains positive, positioning hemodialysis equipment as a critical component of global renal care management.
Segmentation By Product
By End-user
By Region